BRIEF published on 07/30/2025 at 07:40, 1 year ago Michael Friede Joins Symrise as Executive Board Member and President of Scent & Care Executive Board Symrise AG Fragrance Industry Scent & Care Michael Friede
PRESS RELEASE published on 07/30/2025 at 07:35, 1 year ago Michael Friede has been appointed Symrise Executive Board Member and President Scent & Care Symrise AG appoints Michael Friede as Executive Board Member and President Scent & Care segment, bringing extensive international management experience and industry-specific knowledge President Symrise AG Executive Board Member Scent & Care Michael Friede
BRIEF published on 07/30/2025 at 07:35, 1 year ago Symrise Posts First Half 2025 Results with Steady Growth EBITDA Margin Organic Growth 2025 Results Symrise ONE SYM Strategy
PRESS RELEASE published on 07/30/2025 at 07:30, 1 year ago Symrise Reports First Half 2025 Results Symrise AG reports organic growth and increased EBITDA margin in H1 2025 results, appoints new Executive Board Member, and updates guidance amidst global demand shifts EBITDA Margin Organic Growth Global Demand Symrise AG H1 2025 Results
BRIEF published on 04/29/2025 at 07:35, 1 year 3 months ago Symrise Reports Solid Q1 Growth and Confirms Year-End Targets EBITDA Margin Organic Growth Market Expansion Taste And Scent ONE Symrise Strategy
PRESS RELEASE published on 04/29/2025 at 07:30, 1 year 3 months ago Symrise delivers solid growth in Q1 and reaffirms outlook Symrise AG reports solid Q1 growth with organic growth of 4.2% and reaffirms 2025 outlook, driven by higher volumes. Strategic assessment of Chemicals Production activities conducted Organic Growth Symrise AG Q1 Growth 2025 Outlook Chemicals Production
BRIEF published on 03/27/2025 at 07:35, 1 year 4 months ago Symrise Increases Dividend and Confirms Growth Targets Growth Strategy Dividend Increase Symrise AG Sustainability Initiatives Annual Report 2024
PRESS RELEASE published on 03/27/2025 at 07:30, 1 year 4 months ago Symrise raises dividend and confirms outlook Symrise AG raises dividend to € 1.20 per share for 2024, confirms 2025 outlook with 5-7% organic growth target and 21% EBITDA margin, extends Executive Board contract Organic Growth Dividend Increase Symrise AG 2025 Outlook Executive Board Contract Extension
BRIEF published on 02/21/2025 at 10:20, 1 year 5 months ago Symrise Partners with HBC to Enhance Health and Nutrition Offerings Sustainability Symrise HBC Partnership Marine Ingredients Health Nutrition
PRESS RELEASE published on 02/21/2025 at 10:15, 1 year 5 months ago Symrise accelerates in Human Health and Pet Nutrition through a strategic partnership with HBC Symrise accelerates in Human Health and Pet Nutrition with strategic partnership with HBC, expanding into clinically proven marine ingredients for health and nutrition markets Strategic Partnership Pet Nutrition Symrise Human Health HBC
Published on 08/03/2026 at 23:00, 2 hours 45 minutes ago Viemed Healthcare Announces Second Quarter 2026 Financial Results
Published on 08/01/2026 at 01:20, 3 days ago Gamma Resources Announces $880,000 Private Placement with Full Warrant Coverage
Published on 08/01/2026 at 01:15, 3 days ago Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination
Published on 08/01/2026 at 00:30, 3 days 1 hour ago Battery X Metals Announces Amendment to Corporate Awareness Engagement
Published on 08/03/2026 at 23:33, 2 hours 11 minutes ago EQS-Adhoc: Verbio SE: Preliminary EBITDA for FY 2025/2026 exceeds forecast
Published on 08/03/2026 at 23:20, 2 hours 24 minutes ago DeFi Technologies Announces Shareholder Call to Discuss Q2 2026 Financial Results
Published on 08/03/2026 at 21:39, 4 hours 5 minutes ago PAUL Tech AG reports net income after tax of EUR 3.2 million for fiscal year 2025 and issues a positive outlook for fiscal year 2026
Published on 08/03/2026 at 19:35, 6 hours 9 minutes ago Enzene Launches NeX™, a Comprehensive Suite of Solutionsto Enable Cost-Efficient, High-Yielding Local Biomanufacturing
Published on 08/03/2026 at 19:01, 6 hours 44 minutes ago EQS-Adhoc: Fresenius Medical Care AG : Fresenius Medical Care reports operating income excluding special items to be above market expectations in Q2 2026 and confirms its outlook for the financial year 2026
Published on 08/03/2026 at 18:45, 7 hours ago Covivio - Information on total number of voting rights and share capital
Published on 08/03/2026 at 17:45, 8 hours ago Monthly disclosure of the total number of shares and voting rights - July 2026
Published on 08/03/2026 at 17:40, 8 hours 5 minutes ago Eiffage announces the end of exclusive negotiations with Atlas Arteria for the possible acquisition of the Warnow Tunnel concession in Rostock, Germany
